Clearcut Surgical develops an integrated surgical device combining electrosurgery, continuous smoke evacuation, and on-demand fluid suction. This all-in-one tool is designed to enhance efficiency and safety for surgical teams during procedures. The device aims to improve overall operative outcomes by streamlining essential functions into a single platform.

Ecolumix provides EHS intelligence by mining billions of verified data points to measure corporate environmental, health, and safety performance. This data allows companies to accurately assess compliance risks, evaluate supplier performance, and benchmark against industry peers. The platform delivers actionable analytics to improve operational efficiency and meet strategic sustainability goals.

This biotech company develops novel therapeutics for cancer and autoimmune diseases. Their focus is on creating innovative treatments that improve patient quality of life and survival rates.

WispnScience develops AI-driven sensors that detect drink spiking and other hidden dangers in real-time, providing users with immediate alerts to enhance personal safety in social settings. Their discreet devices integrate seamlessly into everyday life, empowering individuals to take proactive measures against potential threats.

Onbrand PLM is a cloud‑based product lifecycle management platform for apparel, footwear, and consumer brands that centralizes styles, tech packs, materials, colors, and artwork in a single source of truth. It enables real‑time collaboration, automated approval workflows, and AI‑assisted design to accelerate tech pack creation and reduce development cycles.

Qnity develops a quantum-electrochemical device featuring a custom chip with nano-gold silicon electrodes for molecular screening. This platform delivers ultra-sensitive, real-time binding affinity and kinetic analysis for drug discovery across all molecule sizes. The technology enables faster, more precise screening capabilities at attomolar concentrations.

Remedium Bio has developed the Prometheus™ adjustable gene therapy platform, which enables the localized delivery of therapeutic genes through a single subcutaneous injection, allowing for precise post-treatment dose adjustments. The company addresses significant clinical needs by providing durable alternatives to protein-based therapies for conditions such as obesity, type 2 diabetes, and osteoarthritis, potentially reducing treatment costs and improving patient outcomes.